Advertisement

Performance and Quality Control of the 99Mo/99mTc Generator

  • I. Zolle
Chapter

5.5 Conclusions

Generator function and the purity of 99mTc eluates of the available fission 99Mo generators in Europe have been investigated by several European research institutions over the years. Much information on the benefits of improved technology has been documented, testifying to high standards of manufacturing and to the reliability of validation processes implemented by the regulatory agencies for safe application of the 99Mo/99mTc generator in nuclear medicine.

Several European centers were engaged in implementing GMP standards for the preparation of 99mTc radiopharmaceuticals in nuclear medicine, and thus have contributed to establish a protocol for analytical procedures, which can validate the performance of generator systems from different manufacturers and assure the quality of short-lived generator eluates. The protocol is presented in Appendix Al of this chapter.

Keywords

Elution Efficiency Daughter Activity Daughter Radionuclide Radionuclide Generator Sodium Pertechnetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barnes RK, Boyd RE (1982) The chromatographic extraction and purification of 99Mo from uranium solutions by use of a silver impregnated alumina stationary phase. Int J Appl Radiat Isot 33:479–481CrossRefGoogle Scholar
  2. Bonnyman J (1983) Effect of milking efficiency on Tc-99 content of Tc-99m derived from Tc-99m generators. Int J Appl Radiat Isot 34:901–906PubMedCrossRefGoogle Scholar
  3. Boyd RE (1973) Recent developments in generators of 99mTc (IAEA-SM-171/94) In: Radiopharmaceuticals & labelled compounds 1973. IAEA Vienna, pp 3–26Google Scholar
  4. Boyd RE (1982) Technetium-99m generators — the available options. Int J Appl Radiat Isot 33:801–810PubMedCrossRefGoogle Scholar
  5. Boyd RE, Hetherington ELR, Moore PW (1985) Radionuclide generator technology. In: Radiophar-maceuticals & labelled compounds 1984. IAEA Vienna, 79–94Google Scholar
  6. Brandau W, Hotze L-A, Meyer G-J (1996) Radiochemie. In: Bull U, Schicha H, Biersack H-J, Knapp WH, Reiners Chr, Schober O (eds) Nuklearmedizin [in German]. Georg Thieme, Stuttgart, pp 79–113Google Scholar
  7. Briner WH, Harris CC (1974) Radionuclide contamination of eluates from fission-product molybdenum-technetium generators. J Nucl Med 15:466–467PubMedGoogle Scholar
  8. Council of Europe (2005a) Sodium pertechnetate[99mTc] injection (fission). Monograph No. 124. European Pharmacopoeia, 5th edn., Maisonneuve, Sainte-RuffineGoogle Scholar
  9. Council of Europe (2005b) Sodium pertechnetate[99mTc] injection (nonfission). Monograph No. 283. European Pharmacopoeia, 5th edn. Maisonneuve, Sainte-RuffineGoogle Scholar
  10. Eckelman WC, Coursey BM (1982) Technetium-99m: generators, chemistry and preparation of radiopharmaceuticals. Int J Appl Radiat Isot 33:793–890CrossRefGoogle Scholar
  11. Feigl F (1958) Spot tests in inorganic analysis, 5th edn. Elsevier, Amsterdam, p. 145Google Scholar
  12. Hammermaier A, Reich E, Endrulat HJ, Bögl W (1985) Investigations on the quality of eluates from seven fission Mo-99/Tc-99m-generators. Institute for Radiation Hygiene of the Federal Health Office, Neuherberg, Germany. ISH Report 64.Google Scholar
  13. Hammermaier A, Reich E, Bogl W (1986) Chemical, radiochemical, and radionuclidic purity of eluates from different commercial fission 99Mo/99mTc generators. Eur J Nucl Med 12:41–46PubMedCrossRefGoogle Scholar
  14. Lin MS, McGregor RD, Yano Y (1971) Ionic aluminium (III) in generator eluate as an erythrocyte-agglutinating agent. J Nucl Med 12:297–299PubMedGoogle Scholar
  15. Marengo M, Aprile C, Bagnara C, Bolzati C, Bonada C, Candini G, Casati R, Civollani S, Colombo FR, Compagnone G, Del Dottore F, Di Guglielmo E, Ferretti PP, Lazzari S, Minoia C, Pancaldi D, Ronchi A, Sanita di Toppi G, Saponaro R, Torregiani T, Uccelli L, Vecchi F, Piffanelli A (1999) Quality control of 99Mo/99mTc-generators: results of a survey of the radiopharmacy working group of the Italian Association of Nuclear Medicine (AIMN) Nucl Med Commun 20:1077–1084Google Scholar
  16. Molinski VJ (1982) A review of 99mTc-generator technology. Int J Appl Radiat Isot 33:811–820CrossRefGoogle Scholar
  17. Nordic Council on Medicines (1989) Nordic guidelines. Radiopharmacy — preparation and control of radiopharmaceuticals in hospitals. NLN Publication No. 26, UppsalaGoogle Scholar
  18. Ponto JA, Swanson DP, Freitas JE (1987) Clinical manifestations of radio-pharmaceutical formulation problems. In: Hladik WB III, Saha GB, Study KT (eds) Essentials of nuclear medicine science. Williams & Wilkins, Baltimore, pp 270–274Google Scholar
  19. Richards P (1966) Nuclide generators. In: Radioactive Pharmaceuticals. USAEC Symposium Series, No. 6, (CONF-651111). Oak Ridge, Tennessee, pp 155–163Google Scholar
  20. Richards P, O’Brien MJ (1969) Rapid determination of 99Mo in separated 99mTc. J Nucl Med 10:517PubMedGoogle Scholar
  21. Richards P, Tucker WD, Srivastava SC (1982) Technetium-99m: an historical perspective. Int J Appl Radiat Isot 33:793–800PubMedCrossRefGoogle Scholar
  22. Robson J (1972) Process for the production of technetium-99m from neutron irradiated molybdenum trioxide — assigned to the AAEC patents: UK (40273/72), USA (284,868), Sweden (10868/ 72), Japan (85901/1972)Google Scholar
  23. Shukla SK, Manni GB, Cipriani C (1977) Effect of aluminium impurities in the generator-produced pertechnetate-99m ion on thyroid scintigrams. Eur J Nucl Med 2:137–141PubMedCrossRefGoogle Scholar
  24. United States Pharmacopeial Convention (2005) Official monographs: USP 28, sodium pertechnetate Tc99m injection. United States pharmacopeia (USP) 28 — national formulary (NF) 23, p 1861Google Scholar

Copyright information

© Springer Berlin Heidelberg 2007

Authors and Affiliations

  • I. Zolle
    • 1
  1. 1.Department of Medicinal/Pharmaceutical ChemistryUniversity of ViennaViennaAustria

Personalised recommendations